CBLL
Ceribell, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$27.75
−1.86%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$22.05
From 52W high−1.86%
Volume617129.00
Market cap$1.08B
P/E (TTM)—
P/S (TTM)9.9x
Div yield—
Key dataNov 4, 2026
Open
$22.05
From 52W high
−1.86%
Volume
617129.00
Market cap
$1.08B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−13.8x
P/E (TTM)
—
RSI (14)
55.0
MomentumView details →
1D Return
−1.86%
YTD Return
+23.76%
SummaryUpdated Sep 1, 2026
CeriBell, Inc. (NASDAQ:CBLL) is a medical device company founded in 2014 and based in Sunnyvale, California. Originally incorporated as Brain Stethoscope, Inc., the company changed its name to CeriBell in August 2015. CeriBell has developed artificial intelligence-powered point-of-care electroencephalography (EEG) technology designed to detect and monitor neurological conditions in acute care settings. The company went public and has established itself as a leader in seizure detection technology, with its systems having been used on over 200,000 patients across more than 500 active hospital accounts.
Similar companies
Latest newsMore news →
Ceribell, Inc. reported a third-quarter loss of $0.48 per share, compared with a loss of $0.37 per share a year earlier.15h agoCeribell reported financial results for the third quarter ended September 30, 2026.20h agoCeribell announced the commercial launch of its delirium monitoring solution on its point-of-care brain monitoring platform.2d ago